加强喘生物药物临床途径的混合方法评估在英国西米德兰兹地区
Sarah Damery1, Janet Jones2, Elfatih Idris3
1Institute of Applied Health Research, University of Birmingham, Edgbaston, West Midlands, B15 2TT, UK. s.l.damery@bham.ac.uk.
NPJ primary care respiratory medicine
|May 1, 2024
概括
一个增强的严重喘途径显著减少了等待时间和改善了患者的结果,包括更少的恶化和住院治疗. 这突显了优化推系统的潜力,以解决严重喘护理的未满足需求.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 生物治疗可为严重喘提供缓解,但由于服务能力有限和初级保健转诊率低,面临挑战.
- 尽管可用于治疗严重喘的有效生物疗法,但患者的未满足需求仍然存在.
研究的目的:
- 为了评估一个混合方法增强严重喘途径在斯塔福德郡和斯托克-上-特伦特,英国.
- 优化初级保健转诊,增加重症喘患者的专科诊所容量.
主要方法:
- 混合方法评估,包括对等待时间,处方,恶化,入院和喘控制的定量分析.
- 与12个利益相关者进行定性访谈,以评估对增强途径的看法.
主要成果:
- 等待时间从平均76.4周减少到26.7周 (p < 0.001).
- 服用生物药物的患者减少了缓解吸入器的使用 (p=0.037),减少了60%的口服类固醇使用 (p < 0.001),减少了恶化和入院 (p < 0.001).
- 喘控制得分显著改善 (p < 0.001).
结论:
- 增强的严重喘途径显著改善了患者的治疗结果,并减少了等待时间.
- 利益相关者的反是积极的,但在初级保健参与和能力方面仍然存在挑战.
- 该途径显示了日常实施的潜力,以解决严重喘护理的大量未满足需求.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
279
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
279
Antiasthma Drugs: β2-Adrenoceptor Agonists
255
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
255
COPD: Management Using Bronchodilators and Corticosteroids
198
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
198
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Drugs Used in Lower Respiratory Disorders: Overview
424
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
424


